45
Participants
Start Date
May 31, 2012
Primary Completion Date
August 31, 2015
Study Completion Date
September 30, 2015
S-488410
In multicenter HLA-blinded open study, patients will be vaccinated subcutaneously once a week with S-488410 (S-488401, S-488402, S-488403, 1mg each).
Department of Medical Oncology, Shiga University of Medical Science Hospital, Ōtsu
Collaborators (1)
Showa University
OTHER
Fukushima Medical University
OTHER
Tohoku University
OTHER
Shionogi
INDUSTRY
Tokyo University
OTHER
University of Chicago
OTHER
Shiga University
OTHER